InvestorsHub Logo
Followers 5
Posts 56
Boards Moderated 0
Alias Born 06/28/2020

Re: randychub post# 12385

Saturday, 08/22/2020 11:17:51 AM

Saturday, August 22, 2020 11:17:51 AM

Post# of 44690
From the Article in Bio-World

"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials"

Very good news.